Cargando…
An optimized cultivation method for future in vivo application of γδ T cells
γδ T cells, with their properties of both the innate and acquired immune systems, are suitable candidates for cellular immunotherapy in cancer. Because of their non-major histocompatibility complex (MHC) binding T cell receptor, allogenic transfer is feasible without relevant graft versus host react...
Autores principales: | Bold, Anna, Gross, Heike, Holzmann, Elisabeth, Knop, Stefan, Hoeres, Timm, Wilhelm, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394837/ https://www.ncbi.nlm.nih.gov/pubmed/37539052 http://dx.doi.org/10.3389/fimmu.2023.1185564 |
Ejemplares similares
-
Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer
por: Hoeres, Timm, et al.
Publicado: (2018) -
Monitoring Circulating γδ T Cells in Cancer Patients to Optimize γδ T Cell-Based Immunotherapy
por: Oberg, Hans-Heinrich, et al.
Publicado: (2014) -
γδ T Cells in HIV Disease: Past, Present, and Future
por: Pauza, C. David, et al.
Publicado: (2015) -
Tafasitamab mediates killing of B-cell non-Hodgkin’s lymphoma in combination with γδ T cell or allogeneic NK cell therapy
por: Her, Jung Hyun, et al.
Publicado: (2022) -
γδ T cells and their clinical application in colon cancer
por: Corsale, Anna Maria, et al.
Publicado: (2023)